The trial, called DIAMOND, is the first prospective phase 3 trial which is assessing the rapid initiation of a single-tablet regimen (STR) SYMTUZA for the treatment of human
The post Janssen’s HIV drug SYMTUZA yields positive results in DIAMOND trial appeared first on Pharmaceutical Business review.
Original Article: Janssen’s HIV drug SYMTUZA yields positive results in DIAMOND trial